Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs
Abstract Prostate cancer (PC) progression and mortality are largely driven by therapeutic resistance, increasingly linked to dynamic tumor–stroma interactions. However, the molecular basis of cancer–fibroblast crosstalk remains incompletely understood, particularly the contribution of Interleukin (I...
I tiakina i:
| Ngā kaituhi matua: | , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Springer
2026-06-01
|
| Rangatū: | Molecular Biomedicine |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s43556-026-00482-9 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|